science
Patients with rare and serious diseases have complex medical challenges that they face on a daily basis. Our science is rooted in finding potential solutions to those challenges, with a focus on meeting the needs of patients who currently have limited or no treatment options.
As we bring forward our pipeline of potential new therapies, we continue to seek new approaches to challenges that have confounded the medical community, leaving patients with no answers.
Insmed is advancing a pipeline to bring potential treatments to patients with rare and serious diseases.
Our proprietary liposomal technology was designed to deliver medicine directly to the lung.
Insmed’s primary area of focus is nontuberculous mycobacterial (NTM) lung disease. We are also exploring other rare and serious diseases with significant unmet needs.
Insmed supports medical and scientific research conducted by external scientists, clinicians, and organizations that aligns with our areas of interest.
We actively conduct clinical trials to advance the development of our product candidates and better understand their benefit/risk profiles.
Insmed Incorporated © 2019 All rights reserved.
Insmed Incorporated © 2019 All rights reserved.
Insmed, ARIKAYCE, Arikares, and PULMOVANCE are trademarks of Insmed Incorporated. All other trademarks are property of their respective owner.
© Insmed 2019. All Rights Reserved.Terms of UsePrivacy Policy